Leukotriene A4 hydrolase as a target for cancer prevention and therapy

被引:89
作者
Chen, X [1 ]
Wang, S [1 ]
Wu, N [1 ]
Yang, CS [1 ]
机构
[1] Rutgers State Univ, Susan Lehman Cullman Lab Canc Res, Dept Chem Biol, Ernest Mario Sch Pharm, Piscataway, NJ 08854 USA
关键词
D O I
10.2174/1568009043333041
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Leukotriene A4 hydrolase (LTA4H) is a bifunctional zinc enzyme with the activities of epoxide hydrolase and aminopeptidase. As an epoxide hydrolase, LTA4H catalyzes the hydrolysis of the epoxide LTA4 to the diol, leukotriene B4 (LTB4), which mainly functions as a chemoattractant and an activator of inflammatory cells. As an aminopeptidase, LTA4H may process peptides related to inflammation and host defense. In a chronic inflammation-associated animal model of esophageal adenocarcinoma, we have shown that LTA4H was overexpressed in tumor as compared to normal tissues. Bestatin, an LTA4H inhibitor, suppresses tumorigenesis in this animal model. Since LTA4H has long been regarded as an anti-inflammatory target, we propose LTA4H as a target for prevention and therapy of cancers, especially those associated with chronic inflammation. Here we review the gene structure, expression, regulation and functions of LTA4H, as well as its involvement in carcinogenesis. We believe LTA4H/LTB4 may play an important role in chronic inflammation associated carcinogenesis by at least two mechanisms: a) the inflammation-augmenting effect on inflammatory cells through positive feedback mediated by its receptors and downstream signaling molecules; and b) the autocrine growth-stimulatory effect of LTB4 produced by epithelial cells, and the paracrine growth-stimulatory effect of LTB4 produced by inflammatory cells, on precancerous and cancer cells. Based on our present knowledge, inhibitors of LTA4H or antagonists of LTB4 receptors may be used alone or in combination with other agents (e.g., cyclooxygenase 2 inhibitors) in cancer prevention and treatment trials to test their effectiveness.
引用
收藏
页码:267 / 283
页数:17
相关论文
共 282 条
[21]   Measurement of muscle protein degradation in live mice by accumulation of bestatin-induced peptides [J].
Botbol, V ;
Scornik, OA .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1997, 273 (06) :E1149-E1157
[22]  
Brady HR, 1997, ADV EXP MED BIOL, V400, P631
[23]   LIPOXYGENASE PRODUCT FORMATION AND CELL-ADHESION DURING NEUTROPHIL GLOMERULAR ENDOTHELIAL-CELL INTERACTION [J].
BRADY, HR ;
LAMAS, S ;
PAPAYIANNI, A ;
TAKATA, S ;
MATSUBARA, M ;
MARSDEN, PA .
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL FLUID AND ELECTROLYTE PHYSIOLOGY, 1995, 268 (01) :F1-F12
[24]   ADHESION PROMOTES TRANSCELLULAR LEUKOTRIENE BIOSYNTHESIS DURING NEUTROPHIL-GLOMERULAR ENDOTHELIAL-CELL INTERACTIONS - INHIBITION BY ANTIBODIES AGAINST CD18 AND L-SELECTIN [J].
BRADY, HR ;
SERHAN, CN .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (03) :1307-1314
[25]   Co-localization of leukotriene A4 hydrolase with 5-lipoxygenase in nuclei of alveolar macrophages and rat basophilic leukemia cells but not neutrophils [J].
Brock, TG ;
Maydanski, E ;
McNish, RW ;
Peters-Golden, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) :35071-35077
[26]   Modulators of leukotriene biosynthesis and receptor activation [J].
Brooks, CDW ;
Summers, JB .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (14) :2629-2654
[27]   Leukotrienes and inflammation [J].
Busse, WW .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (06) :S210-S213
[28]  
Byrum RS, 1999, J IMMUNOL, V163, P6810
[29]   Role of the 5-lipoxygenase-activating protein (FLAP) in murine acute inflammatory responses [J].
Byrum, RS ;
Goulet, JL ;
Griffiths, RJ ;
Koller, BH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (06) :1065-1075
[30]   Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening [J].
Carson, DD ;
Lagow, E ;
Thathiah, A ;
Al-Shami, R ;
Farach-Carson, MC ;
Vernon, M ;
Yuan, LW ;
Fritz, MA ;
Lessey, B .
MOLECULAR HUMAN REPRODUCTION, 2002, 8 (09) :871-879